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Abstract
Chemically defined serum-free media for rat hepatocytes have been useful in identifying EGFR ligands and HGF/MET
signaling as direct mitogenic factors for rat hepatocytes. The absence of such media for mouse hepatocytes has prevented
screening for discovery of such mitogens for mouse hepatocytes. We present results obtained by designing such a
chemically defined medium for mouse hepatocytes and demonstrate that in addition to EGFR ligands and HGF, the growth
factors FGF1 and FGF2 are also important mitogenic factors for mouse hepatocytes. Smaller mitogenic response was also
noticed for PDGF AB. Mouse hepatocytes are more likely to enter into spontaneous proliferation in primary culture due to
activation of cell cycle pathways resulting from collagenase perfusion. These results demonstrate unanticipated
fundamental differences in growth biology of hepatocytes between the two rodent species.
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Introduction
Primary cultures of rodent and human hepatocytes have been
used as tools for studies of metabolism, drug toxicity, bile acid
synthesis, and many other aspects of hepatic physiology. In
addition, growth of rat hepatocytes in primary culture and in
chemically defined (serum-free) media has been a very useful tool
for determining growth factors (Hepatocyte Growth Factor (HGF),
and Epidermal Growth Factor Receptor (EGFR) ligands) that are
direct mitogens for rat hepatocytes [1]. These studies paved the
progress made for determining the role of EGFR and MET (the
HGF receptor) receptors and their ligands in liver regeneration
and hepatocyte growth [2–5]. While the conditions for hepatocyte
growth in chemically defined media have been well defined for the
rat [1], definition of similar conditions for mouse hepatocytes has
been elusive. Response of mouse hepatocytes to established
mitogens such as HGF and EGF in most media has been
mediocre at best compared to rat hepatocytes.
The work presented in this manuscript describes a chemically
defined serum-free medium that allows growth of mouse
hepatocytes in primary culture and high response to growth
factors comparable to those seen with the rat. The medium was
substantially modified from the hepatocyte growth medium
(HGM) used for rat hepatocytes [1]. During the course of thee
studies, we also determined that whereas EGFR ligands and HGF
are the major direct mitogens for rat hepatocytes, Fibroblast
Growth Factors 1 and 2 (FGF1, FGF2) are equally strong direct
mitogens for mouse hepatocytes. Platelet Derived Growth Factor
(PDGF) also has a weaker direct mitogenic effect. These findings
present hitherto undiscovered differences in growth biology of
hepatocytes between the two rodent species most commonly used
for studies of liver regeneration and carcinogenesis. This work
needs to be extended to human hepatocytes. Our work also
describes technical difficulties in applying common methodologies
used to assess cell proliferation in culture.
Materials and Methods
Ethics Statement
Animals (mice) were housed and treated according to institu-
tional guidelines of the University of Pittsburgh IACUC commit-
tee (Protocol 1105844). This follows guidelines established by NIH
for ethical use of animals in biomedical research. The IACUC
committee and the aforementioned protocol specifically approved
this study.
Male Fisher 344 rats (2–3 months of age) were purchased from
Harlan. Male FVB mice (2–3 months of age) were purchased from
Charles River. Animals were allowed food and water ad libitum
and handled according to the Ethics Statement above.
Methods for Alleviation of Animal Suffering
Mice and rats were used to isolate hepatocytes by perfusion of
the liver with collagenase. All animals were deeply anesthetized by
injection of Nembutal. Surgical exposure of the liver for
collagenase perfusion was performed only after the animals were
completely anesthetized.
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Isolation and Culture of Hepatocytes
Hepatocytes were isolated by adaptation of the calcium two-step
collagenase perfusion technique as previously described [6].
Hepatocytes were plated on collagen-coated six-well plates (BD
Biosciences, San Jose, CA) at 250,000 cells/well. After the initial 2-
hour attachment period, the medium was changed to formulations
as described in Results. There was no serum added at any time
during or after plating of hepatocytes. The various growth factors,
for either mouse or rat hepatocytes, were added at 24 hours after
plating. Media were changed every 48 hours, except for the first
medium change, which was done at 24 hours after plating and was
used to introduce the added growth factors. Cells were harvested
for assessment of cell proliferation at the times indicated in the
relevant figures.
Formulation of the HGM (Hepatocyte Growth Medium)
and MHGM (Mouse Hepatocyte Growth Medium)
The formulation of HGM medium has been previously
described and was the basis of modifications for the formulation
of the MHGM medium.
HGM medium. DMEM (Dulbecco’s minimal essential me-
dium), Hepes, glutamine, and antibiotics were purchased from
GIBCO/BRL (Gaithersburg, MD). ITS mixture (Insulin, Trans-
ferrin, Selenium) was purchased from Boehringer Mannheim. All
other additives were cell culture grade (Sigma). Unless otherwise
indicated for specific experiments, the basal HGM medium
consisted of DMEM supplemented with: purified bovine albumin
2.0 gm/L, glucose 2.25 gr/L, galactose 2.0 gr/L, ornithine
0.1 gm/L, proline 0.030 gm/L, nicotinamide 0.610 gm/L, ZnCI2
0.544 mg/L, ZnSO4:7H2O 0.750 mg/L, CuSO4:5H2O
0.20 mg/L, MnSO4 0.025 mg/L, glutamine 5.0 mM, ITS
1.0 gm/L, (rh-insulin 5.0 mg/L, human transferrin 5.0 mg/L
[30% diferric iron saturated], selenium 5.0 mg/L), and dexameth-
asone 1027 M. Penicillin and streptomycin were added to the
basal HGM at 100 mg/L each. The mixed basal HGM was
sterilized by filtration through a 0.22-mm low protein-binding filter
system, stored at 4uC, and used within 4 wk. The growth factors,
as required, were added to medium fresh at the specified
concentrations every time the medium was changed.
MHGM medium. MHGM was derived by using E-MEM
(from Sigma) instead of DMEM as the basis for the formulation.
Nicotinamide was omitted and dexamethasone was added at a
final concentration of 1026 M (ten times more than HGM).
Glucose concentration for MHGM 4.5 mg/ml) was also adjusted
to two-fold that of HGM.
Hepatocyte Proliferation Assay
Measurement of DNA synthesis.
1. Thymidine incorporation. H3]Thymidine was added to
the medium at 24 hours at a concentration of 2.5 mCi/ml. The
medium was removed when the cultures were harvested and
hepatocytes were fixed with ice-cold 5% trichloroacetic acid.
Trichloroacetic acid was removed and the plates were washed in
running tap water and air-dried completely. Then 750 mL 0.33 M
NaOH was added to each well for 30 minutes to solubilize the
cells. The solution was transferred to a new tube and 250 mL of
40% TCA/1.2 M HCl was added for precipitation. The tubes
were centrifuged at 12,000 g for 10 minutes and the pellets were
dissolved in 500 mL 0.33 M NaOH. A 200-mL aliquot was used to
measure G3 cpm in a Beckman LS6000IC scintillation counter
(Beckman Coulter, CA) and 100 mL was used to determine optical
density value of total DNA. Data are plotted as CPM/mg DNA.
BRDU incorporation into DNA was assessed by the use of the
Invitrogen BRDU staining kit (from Life Technologies).
2. Bromodeoxyuridine (BRDU) and Ki67
immunohistochemistry. Ki-67 antibodies were obtained from
Santa Cruz. BRDU immunohistochemistry was performed using
the specific kit from Becton-Dickinson.
Concentrations of mitogenic growth factors. We per-
formed dose-response studies (data not shown) and assessed that
40 ng/per ml exceeded the highest dose response for each growth
factor. They were all added to the medium at 40 ng/ml to assure
maximal response.
Transmission electron microscopy. Hepatocytes grown
on tissue culture collagen coated plates were fixed in 2.5%
glutaraldehyde in 100 mM PBS (8 gm/l NaCl, 0.2 gm/l KCl,
1.15 gm/l Na2HPO4
.7H2O, 0.2 gm/l KH2PO4, pH 7.4 ) over-
night at 4uC. Hepatocyte monolayers were then washed in PBS
three times then post-fixed in aqueous 1% osmium tetroxide, 1%
Fe6CN3 for 1 hr. Cells were washed 3 times in PBS then
dehydrated through a 30–100% ethanol series then several
changes of Polybed 812 embedding resin (Polysciences, Warring-
ton, PA). Cultures were embedded in by inverting Polybed 812-
filled BEEM capsules on top of the cells. Blocks were cured
overnight at 37uC, then cured for two days at 65uC. Monolayers
were pulled off the coverslips and re-embedded for cross section.
Ultrathin cross sections (60 nm) of the cells were obtained on a
Riechart Ultracut E microtome, post-stained in 4% uranyl acetate
for 10 min and 1% lead citrate for 7 min. Sections were viewed on
a JEOL JEM 1011 transmission electron microscope (JEOL,
Peobody MA) at 80 KV. Images were taken using a side-mount
AMT 2 k digital camera (Advanced Microscopy Techniques,
Danvers, MA).
Results
Formulation of MHGM Medium for Mouse Hepatocytes
Our initial studies with mouse hepatocytes in the rat-defined
HGM medium showed poor responsiveness to growth factors as
well as substantial ‘‘spontaneous’’ growth of mouse hepatocytes
without serum or any growth factor addition. We have shown in
previous studies in vivo that remodeling of liver extracellular
matrix at the early stages of liver regeneration is associated with
release and activation of HGF [2]. We have also found that pre-
treatment of the liver of live rats with collagenase dramatically
enhanced the mitogenic effects of exogenously administered HGF
[7]. We hypothesized that collagenase perfusion of the mouse liver
to isolate hepatocytes causes disruption of the extracellular matrix
(the very purpose of collagenase perfusion) and results in activation
of cell-cycle driving cascade signaling, perhaps triggered by the
release of matrix-bound HGF. Spontaneous entry of hepatocytes
into cell cycle following isolation by collagenase perfusion has been
previously shown for the rat [8,9]. However, rat hepatocytes do
not enter into DNA synthesis in the absence of growth factors and
there is no high rate of ‘‘spontaneous’’ proliferation of rat
hepatocytes in primary culture. Mouse hepatocytes on the other
hand have highly variable rates in that regard, with BRDU
labeling indices as high as 30%–40% in the first and second day in
primary culture (data not shown) with substantial variation seen
from one hepatocyte isolate to another. This rate of proliferation
subsides by Day 2. Thus we proceeded to conduct our cell
proliferation studies with mouse hepatocytes after 24 hours in
primary culture and maintained mouse hepatocytes in plain
medium without any addition of serum from the time of plating to
the time of harvesting.
FGF and PDGF Are Mitogenic for Mouse Hepatocytes
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We also observed that even starting from 24 hours in culture,
mouse hepatocytes kept in (rat-defined) HGM medium had poor
response to growth factors, as shown in Figure 1. A better response
was seen when the basic formulation of the mouse medium (to be
referred as MHGM) was changed from the HGM basal medium
of DMEM to Eagle’s MEM (EMEM). We did observe however
that addition of HGF and EGF into that medium, while having
minimal effect, was causing substantial vacuolation of the
cytoplasm of the mouse hepatocytes (Figures 2 A and B). Vacuoles
did not contain triglycerides, as evidence by an Oil Red-O stain
(Figure 2 C). The vacuoles were present within the cytoplasm of
hepatocytes and did not represent dilated bile canaliculi or
autophagic vacuoles. The vacuoles did not appear when nicotin-
amide was removed from the medium. It should be noted that no
such effect with nicotinamide was observed with rat hepatocytes
and, to the contrary, presence of nicotinamide was essential for rat
hepatocyte proliferation [1].
Another important factor for the MHGM media formulation
was the concentration of the steroid dexamethasone. Increasing
dexamethasone concentration from 1027 M (in the HGM) to 1026
M in the MHGM medium substantially suppressed the sponta-
neous proliferation rate of mouse hepatocytes without affecting the
response to growth factors (Figure 3).
The detail final formulation and comparison of the ingredients
between the rat hepatocyte-defined HGM medium and the mouse
hepatocyte-optimized MHGM medium are described in Materials
and Methods.
Growth Factors Stimulating Proliferation of Mouse
Hepatocytes in the MHGM Medium
Proliferation of mouse hepatocytes exposed to different growth
factors in the MGM medium is shown in Figure 4. Hepatocytes
were exposed to 2-day pulses of BRDU at the indicated days and
the nuclear labeling index of the cells was assessed. The results
show hepatocyte proliferation rates in response to EGF, HGF,
(EGF plus HGF), and TGFa, primarily at days 4–7 in culture.
Minimal spontaneous proliferation was seen in control cultures
without growth factor addition. We also noticed that FGF1 and
FGF2 had a strong mitogenic effect, something not seen with rat
hepatocytes. Measurable mitogenic effect was also seen with
PDGF AB. Immunohistochemical stains for desmin showed that
the small effect of PDGF AB on cell proliferation was on desmin-
negative cells (hepatocytes) and not on contaminant (desmin
positive) stellate cells. There was no further stimulation of
hepatocyte proliferation by addition of higher concentrations of
PDGF (data not shown).
It should be noted that the results of these studies were obtained
by two-day BRDU pulses. When, instead of BRDU, we used
immunohistochemistry for the cell cycle specific nuclear protein
Ki67, most of the cells appearred positive, whether they were in
control or growth factor-exposed cultures. We consider the
increased expression of Ki67 as part of the overall change in cell
cycle related protein expression induced by the collagenase
perfusion and the culture itself. Expression of cell cycle genes
(but not DNA synthesis) has been observed in the past with rat
Figure 1. Proliferation of mouse hepatocytes maintained in the rat hepatocyte (HGM) medium. Y-axis indicates incorporation of tritiated
thymidine per mg DNA. The growth factors added to the medium are listed under the X-axis. CTR: Control cultures, with no growth factors added.
Growth factors were added at 24 hours after plating of hepatocytes. D 0–2 (etc.) indicates days in culture after addition of the growth factors. (For
growth factor concentration, please see Materials and Methods).
doi:10.1371/journal.pone.0095487.g001
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hepatocytes [9,10]. Since BRDU clearly reflects DNA synhesis, we
considered that as the method of choice to measure the effect of
growth factors on mouse hepatocyte proliferation.
Rat Hepatocytes in the Mouse Medium Perform as
Expected and Reflect Species Differences
We were concerned that the mitogenic effects of FGF1/2 and
PDGF AB on mouse hepatocytes might have been missed with rat
hepatocytes, due to differences in the cell culture medium. To that
end, we assessed proliferation of rat hepatocytes in the MHGM
medium, in exactly the same conditions as with the mouse
hepatocytes. The results are shown in Figure 5. Though overall
proliferation rates were lower than those seen in the HGM
medium, rat hepatocytes responded as previously described, with
very little proliferation in response to FGF1 and much less to
FGF2. No substantial proliferation was induced by PDGF AB.
The lower proliferations rates of rat hepatocytes in MHGM may
be due to the absence of nicotinamide and the higher concentra-
tion of dexamethasone, both of which are likely to negatively affect
rat hepatocyte proliferation, as we have previously described [1].
Interactions between FGF2 and PDGF
Previous studies have shown that in several cell types there is
interaction between PDGF BB and FGF2, as a result of which
FGF2 is often found to inhibit the effects of PDGF BB and vice
versa [11–13](see Discussion). In order to investigate such
interaction between FGF2 and PDGF, we explored the rate of
DNA synthesis (assessed by BRDU incorporation) in cultures of
mouse hepatocytes kept in the chemically defined MHGM
medium, and exposed to PDGF AA, PDGF BB in the presence
or absence of FGF2 (Fig. 6). Our results do not show negative
interactions between FGF2 and PDGF AA or BB in terms of
stimulation of DNA synthesis.
Discussion
Our findings demonstrate that there are fundamental differ-
ences in response to growth factors between mouse and rat
hepatocytes in culture, probably as a result of different responses to
degradation of extracellular matrix and release of bound growth
Figure 2. Intense vacuolation of hepatocyte cytoplasm in a preliminary formulation of the mouse hepatocyte growth medium
(MHGM). Elimination of nicotinamide removed this cytoplasmic change. A: Phase contrast photomicrograph of the hepatocytes in culture showing
intense valuation of the cytoplasm (Magnification: 100X). B: Electron micrograph (5,000X) of hepatocytes carrying vacuoles. There is no apparent
connection with bile canaliculi or autophagosomes. C: Oil Red-O stain for lipid demonstrates that the vacuoles observed did not contain lipids.
doi:10.1371/journal.pone.0095487.g002
Figure 3. Suppression of spontaneous proliferation of mouse
hepatocytes in the presence of 1026 M dexamethasone.
Tritiated thymidine was added continually in the cultures, from 4 hours
after cell plating following perfusion of the liver by collagenase.
Cultures were harvested at the indicated time points in the X-axis.
Addition of HGF and EGF is indicated as ‘‘GFs’’. (For growth factor
concentration, please see Materials and Methods).
doi:10.1371/journal.pone.0095487.g003
FGF and PDGF Are Mitogenic for Mouse Hepatocytes
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factors and/or integrin signaling via collagenase perfusion. Our
findings also demonstrate that the family of fibroblast growth
factors (FGF) plays a more important role in mouse hepatocyte
growth biology.
Figure 4. Mouse hepatocyte proliferation in the final formulation of the MHGMmedium. Y-axis indicates percent of labeled nuclei due to
incorporation of bromodeoxyuridine into DNA. The growth factors added to the medium are listed under the X-axis. CTR: Control cultures, with no
growth factors added. Growth factors were added at 24 hours after plating of hepatocytes. D 0–2 (etc.) indicates days in culture after addition of the
growth factors. (For growth factor concentration, please see Materials and Methods).
doi:10.1371/journal.pone.0095487.g004
Figure 5. Rat hepatocyte proliferation in the MHGM medium. Y-axis indicates percent of labeled nuclei due to incorporation of
bromodeoxyuridine into DNA. The scale of Y-axis is kept identical to that of figure 4, for direct comparison of the responses of mouse and rat
hepatocytes. The growth factors added to the medium are listed under the X-axis. CTR: Control cultures, with no growth factors added. Growth
factors were added at 24 hours after plating of hepatocytes. D 0–2 (etc.) indicates days in culture after addition of the growth factors. (For growth
factor concentration, please see Materials and Methods).
doi:10.1371/journal.pone.0095487.g005
FGF and PDGF Are Mitogenic for Mouse Hepatocytes
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Previous studies have demonstrated that FGF1 and FGF2 may
contribute to hepatocyte growth. Detail studies have shown that
hepatocytes express the fibroblast growth factor receptor FGFR4
but not the receptors FGFR1 and FGFR2 [14]. The effects of
FGFR4 are dependent on association with the transmembrane
protein bklotho [15]. This protein is often deleted in hepatocel-
lular carcinomas and the results suggest that the interaction of
bklotho and FGFR4 suppress proliferation of neoplastic hepato-
cytes. FGFR1 and FGFR2 are expressed in other hepatic cell types
(endothelial and stellate cells) [16]. FGF1 and FGF2 expression by
hepatocytes increases during liver regeneration [17]. The
increased expression occurs after hepatocytes have already
committed to enter into S phase. Genetic deletion of FGFR4
has been associated with defects in cholesterol and bile acid
metabolism but there were no demonstrable effects on hepatocyte
proliferation in response to injury [14]. In another study, however,
hepatocyte-targeted expression of a dominant negative FGFR2
suppressed and delayed liver regeneration [18]. FGF1 and FGF2
have been associated with induction of the hepatic primordium
from the foregut endoderm [19]. However, mice with combined
deletion of FGF1 and FGF2 have normal embryonic development,
suggesting that the absence of FGF1 and FGF2 is compensated by
other members of the 23-member family of FGFs, which use the
same receptors as FGF1 and FGF2 [16]. Combined FGF1/FGF2
knockout mice do show increased hepatocyte sensitivity to CCl4
but have a decreased level of stellate cell-derived matrix collagen
type 1 synthesis in response to long term CCl4 exposure [16].
Recent studies have also focused on mouse FGF15, the ortholog of
human FGF19. Expression of these FGFs is induced by bile acids
on enterocytes of the ileum. Migration to the liver has endocrine
effects on hepatocyte-mediated cholesterol and bile acid metab-
olism. Mice with systemic genetic elimination of FGF15 had
delayed liver regeneration [20]. Our findings and the studies cited
above suggest that the FGF family members have effects on
hepatocyte growth that need to be further studied and understood
in the context of liver regeneration and chronic liver injury. The
likelihood of important mitogenic effects of FGF members on
hepatocytes is further enhanced by a recent analysis of the signal
transduction pathways of receptor tyrosine kinases. Based on the
inferred signaling networks, that study demonstrated that EGFR,
MET and FGFR1 belong to the same subclass in terms of
intracellular signaling [21].
Much less evidence from the literature exists on effects of PDGF
on hepatocytes. Transgenic over-expression of PDGF C in
hepatocytes was associated with increased activation of stellate
cells, hepatic fibrosis and steatosis, and development of hepato-
cellular carcinoma. It was not clear whether the increased HCC
development was due to direct effects of PDGF or to increased
synthesis of HGF by stellate cells [22]. Hepatocyte targeted genetic
elimination of PDGFRa is associated with delay in liver
regeneration and compensatory increases in EGFR and MET
[23]. There is also increased expression of PDGFRa in mice with
hepatocyte-targeted genetic elimination of beta catenin [24].
Given the smaller response to PDGF compared to the other
mitogenic growth factors, it is conceivable that there is a specific
sub-class of hepatocytes, perhaps related to specific lobular
localization, that have the capacity to respond to PDGF.
Several previous studies have indicated that PDGF BB and
FGF2 exert negative effects on each other’s activities in several cell
types. PDGF BB inhibits angiogenic effects of FGF2 both in vitro
and in vivo, and this action is likely mediated by PDGFRa, since
neutralization of the latter eliminates the inhibitory effects of
PDGF BB [13]. The interaction is complex and involves both the
ligands and their receptors. FGF2 and PDGF BB bind directly
with each other [11]. In addition, there is strong evidence that
FGFR1 and PDGFRa form heterodimers, through which PDGF
BB and FGF2 can have very subtle effects on angiogenesis [12].
The absence of effects of PDGF BB on FGF2 stimulated
hepatocyte DNA synthesis probably reflects different patterns of
receptor interaction. Since FGF2 and PDGF BB bind directly, this
Figure 6. Interactions between FGF2 and PDGF AA and BB in stimulation of DNA synthesis in mouse hepatocyte cultures. Y-axis
indicates percent of labeled nuclei due to incorporation of bromodeoxyuridine into DNA. The growth factors added to the medium are listed under
the X-axis.
doi:10.1371/journal.pone.0095487.g006
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cannot be the reason for the observed lack of interaction in our
study. Localization of receptors on plasma membrane in
hepatocyte cultures, however, is much different than in hepato-
cytes in intact liver [25]. The change of the hepatocyte shape from
cuboidal (in vivo) to a flattened epithelial cell in culture has been
found to have complex effects on intermolecular protein associ-
ations and other structural changes, including absence of bile
canaliculi, etc. Addition of complex matrix material restores such
structures bu it also inhibits hepatocyte DNA synthesis, thus not
allowing a direct study of the PDGF BB and FGF2 interactions in
hepatocytes maintaing proper cell polarity.
In summary, our current study provides information about the
conditions required in cell culture for study of mouse hepatocyte
growth biology and documents that members of the FGF family
and, to a lesser extent, PDGF, should be considered further by
in vivo studies for playing a role in liver regenerative responses.
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